Summary
TORONTO (HedgeWorld.com) - Biovail Corp. has settled a lawsuit against one of the defendants in a lawsuit against research analysts and hedge funds that Biovail claims acted in concert to drive down the company's stock price, which helped short sellers to profit.
The particulars of the settlement with the Band of America analyst David Maris remain secret, but Biovail, a pharmaceutical concern with a market capitalization of $2.5 billion, put out a statement Tuesday [Sept. 11] acknowledging that it is dropping its lawsuit against him. Biovail had claimed that Mr. Maris was one of several research analysts who issued damaging research about Biovail that caused the stock price to fall, benefiting those who sold Biovail stock short.See the full content of this document
Extract
Biovail Settles with Stock Analyst
The settlement with Mr. Maris marks the latest development in a high-profile lawsuit that was featured on the CBS News program "60 Minutes" in March 2006.
Bi...See the full content of this document
Sponsored links
